| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $94.83B | -2.9% |
| Cost of Revenue | $77.73B | -3.1% |
| Gross Profit | $17.09B | -2.0% |
| R&D Expense | $6.41B | +41.2% |
| SG&A Expense | $5.83B | +13.3% |
| Operating Income | $4.36B | -38.5% |
| Pre-tax Income | $5.28B | -41.3% |
| Income Tax | $1.42B | -22.5% |
| Net Income | $3.79B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.51B | +2.3% |
| Short-term Investments | $27.55B | +34.9% |
| Accounts Receivable | $4.58B | +3.6% |
| Inventory | $12.39B | +3.1% |
| Current Assets | $68.64B | +17.6% |
| Total Assets | $137.81B | +12.9% |
| Current Liabilities | $31.71B | +10.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.75B | -1.2% |
| Capital Expenditures | $8.53B | -24.8% |
| Investing Cash Flow | -$15.48B | +17.6% |
| Financing Cash Flow | $1.14B | -70.4% |
| Free Cash Flow | $6.22B | +73.5% |
| -46.5% |
| EPS (Basic) | $1.18 | -47.1% |
| EPS (Diluted) | $1.08 | -47.1% |
| Long-term Debt |
| $6.58B |
| +19.0% |
| Total Liabilities | $54.94B | +13.5% |
| Stockholders' Equity | $82.14B | +12.7% |